Peripheral Nerve Injuries: Clinical Trials

4 trials for Peripheral Nerve Injuries, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 4
Phase 21Completed 1

Follow Peripheral Nerve Injuries: new trials by email Literature Review of Peripheral Nerve Injuries trials Research Report on Peripheral Nerve Injuries

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Autologous Human Schwann Cells in Peripheral Nerve Repair
autologous human Schwann cells - Peripheral Nerve Injuries
Phase 1CompletedW. Dalton Dietrich52019-09-242025-12-12
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
Polyethylene glycol (PEG) - Peripheral Nerve Injury
Phase 1CompletedVanderbilt University Medical Center452019-09-192026-06-15
Study of Capsaicin Patch for the Management of Peripheral Neuropathic Pain
CAPNP, 50 ug/cm2 capsaicin patch, CAPNP, 100 ug/cm2 capsaicin patch, 0.075% capsaicin cream - Peripheral Nerve Injury, Postherpetic Neuralgia
Phase 1 / Phase 2CompletedSamyang Biopharmaceuticals Corporation602009-02-012017-05-01
GW406381 In Patients With Peripheral Nerve Injury
GW406381 - Hyperalgesia, Neurodynia
Phase 1CompletedGlaxoSmithKline402003-09-012009-02-23

Narrower conditions

Hyperalgesia (1)  ·  Neuralgia (1)  ·  Neuralgia, Postherpetic (1)  ·  Pain (1)  ·  Wounds and Injuries (1)

Broader conditions

Nervous System Diseases (4)  ·  Neuromuscular Diseases (4)  ·  Peripheral Nervous System Diseases (4)  ·  Trauma, Nervous System (4)  ·  Wounds and Injuries (3)  ·  Neurologic Manifestations (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Neuralgia (1)  ·  Pain (1)  ·  Sensation Disorders (1)  ·  Somatosensory Disorders (1)

Interventions

GW406381X (1)  ·  Polyethylene Glycols (1)

Sponsors

GlaxoSmithKline (1)  ·  Samyang Biopharmaceuticals Corporation (1)  ·  Vanderbilt University Medical Center (1)  ·  W. Dalton Dietrich (1)

Countries

United States (2)  ·  South Korea (1)  ·  United Kingdom (1)

Top investigators

Allan Levi, MD, PhD (1)  ·  Wesley Thayer, MD (1)

Results publications

PMID 28158151